Purpose
to develop and distribute a high-titered anti-Vi IgG reference serum to facilitate the development of novel efficacious capsular polysaccharide Vi-typhoid conjugate vaccine candidates that may be administered during infancy. This reference serum may obviate the need for manufacturers to undergo costly clinical trials with disease outcomes to potentially having licensed commercial products faster and cheaper
Grantee
Division
Global Health
Date
JUNE 2012
Region served
GLOBAL
Committed amount
$360,593
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
58
Grantee location
Bethesda, Maryland, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.